Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-019990

Chief Business Officer gave up 753 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Luu Brendan Chief Business Officer 2024-12-01 Shares withheld for taxes −753 $8.60 $6,476 38,330 D
Loading xslF345X05/form4.xml…